These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38216706)

  • 1. Morphometric alterations of the mesocorticolimbic network in Parkinson's disease with impulse control disorders.
    Ansari MF; Prasad S; Bhardwaj S; Kamble N; Rakesh K; Holla VV; Yadav R; Mahale RR; Saini J; Pal PK
    J Neural Transm (Vienna); 2024 Mar; 131(3):229-237. PubMed ID: 38216706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders.
    Pellicano C; Niccolini F; Wu K; O'Sullivan SS; Lawrence AD; Lees AJ; Piccini P; Politis M
    J Neurol; 2015 Dec; 262(12):2653-61. PubMed ID: 26410743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical thickness changes in patients with Parkinson's disease and impulse control disorders.
    Tessitore A; Santangelo G; De Micco R; Vitale C; Giordano A; Raimo S; Corbo D; Amboni M; Barone P; Tedeschi G
    Parkinsonism Relat Disord; 2016 Mar; 24():119-25. PubMed ID: 26810913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Weintraub D; Antonini A
    Mov Disord; 2015 Apr; 30(5):688-95. PubMed ID: 25649923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) in an Italian Parkinson's disease cohort.
    Maggi G; Vitale C; Giacobbe C; Barone A; Mastromarino C; Iannotta F; Amboni M; Weintraub D; Santangelo G
    Neurol Sci; 2024 Jul; 45(7):3153-3161. PubMed ID: 38231374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Subcortical Volumes and Cortical Thickness in Parkinson's Disease with Impulse Control Disorders.
    Prasad S; Reddam VR; Stezin A; Yadav R; Saini J; Pal PK
    Ann Indian Acad Neurol; 2019; 22(4):426-431. PubMed ID: 31736563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).
    Marques A; Vidal T; Pereira B; Benchetrit E; Socha J; Pineau F; Elbaz A; Artaud F; Mangone G; You H; Cormier F; Galitstky M; Pomies E; Rascol O; Derkinderen P; Weintraub D; Corvol JC; Durif F;
    Parkinsonism Relat Disord; 2019 Jun; 63():117-123. PubMed ID: 30862454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study.
    Lo Monaco MR; Petracca M; Weintraub D; Fusco D; Liperoti R; Zuccalà G; La Carpia D; Vetrano DL; Genovese D; Pisciotta MS; Brandi V; Padua L; Imbimbo I; Ricciardi D; Bernabei R; Silveri MC; Laudisio A; Bentivoglio AR
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29702754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse control disorders in Parkinson's: Sleep disorders and nondopaminergic associations.
    Carbunaru S; Eisinger RS; Ramirez-Zamora A; Bassan D; Cervantes-Arriaga A; Rodriguez-Violante M; Martinez-Ramirez D
    Brain Behav; 2018 Mar; 8(3):e00904. PubMed ID: 29541533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.
    Leroi I; Barraclough M; McKie S; Hinvest N; Evans J; Elliott R; McDonald K
    J Neuropsychol; 2013 Sep; 7(2):306-25. PubMed ID: 23901888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [
    Pagano G; Molloy S; Bain PG; Rabiner EA; Ray Chaudhuri K; Brooks DJ; Pavese N
    Parkinsonism Relat Disord; 2021 Sep; 90():52-56. PubMed ID: 34385007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders.
    Lee JY; Seo SH; Kim YK; Yoo HB; Kim YE; Song IC; Lee JS; Jeon BS
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):23-30. PubMed ID: 24023269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
    Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
    Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.
    Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Bose S; Lees AJ; Piccini P
    J Neurol; 2015 Jun; 262(6):1504-14. PubMed ID: 25893253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Papay K; Xie SX; Stern M; Hurtig H; Siderowf A; Duda JE; Minger J; Weintraub D
    Neurology; 2014 Aug; 83(9):826-33. PubMed ID: 25037206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease.
    Toś M; Grażyńska A; Antoniuk S; Siuda J
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629758
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.
    Weintraub D; Hoops S; Shea JA; Lyons KE; Pahwa R; Driver-Dunckley ED; Adler CH; Potenza MN; Miyasaki J; Siderowf AD; Duda JE; Hurtig HI; Colcher A; Horn SS; Stern MB; Voon V
    Mov Disord; 2009 Jul; 24(10):1461-7. PubMed ID: 19452562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability.
    Papay K; Mamikonyan E; Siderowf AD; Duda JE; Lyons KE; Pahwa R; Driver-Dunckley ED; Adler CH; Weintraub D
    Parkinsonism Relat Disord; 2011 Mar; 17(3):153-5. PubMed ID: 21186135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.